Volume 20; Issue 4

Main
Investigational New Drugs
Volume 20; Issue 4

Investigational New Drugs

Volume 20; Issue 4

1

Neoadjuvant Chemotherapy with Gemcitabine and Cisplatin in Stage IIIA/B Non-Small Cell Lung Cancer

Maximiliano Van Kooten, Moisés Rosenberg, Mauro Orlando, José Morero, Manuel Vilanova, Oscar Rojas, Héctor Vicente, Claudia Bagnes, Carlos Silva, Reinaldo D. Chacón

Journal:

Investigational New Drugs

Year:

2002

Language:

english

File:

PDF, 100 KB

english, 2002

2

Phase II Study of Marimastat (BB-2516) in Malignant Melanoma – A Clinical and Tumor Biopsy Study of the National Cancer Institute of Canada Clinical Trials Group

Ian Quirt, Audley Bodurtha, Reinhard Lohmann, James Rusthoven, Karl Belanger, Vincent Young, Nancy Wainman, William Steward, Elizabeth Eisenhauer

Journal:

Investigational New Drugs

Year:

2002

Language:

english

File:

PDF, 69 KB

english, 2002

3

Phase I Escalation of Gemcitabine Combined with Protracted Oral Etoposide in Gynecologic Malignancies – A Gynecologic Oncology Group Study

Agustin A. Garcia, Michael A. Bookman, Lorna Rodriguez-Rodriguez, David G. Mutch, Katherine Y. Look

Journal:

Investigational New Drugs

Year:

2002

Language:

english

File:

PDF, 61 KB

english, 2002

4

Instructions for Authors

Journal:

Investigational New Drugs

Year:

2002

Language:

english

File:

PDF, 50 KB

english, 2002

5

Author Index

Journal:

Investigational New Drugs

Year:

2002

File:

PDF, 29 KB

2002

6

Irofulven, a Novel Inhibitor of DNA Synthesis, in Metastatic Renal Cell Cancer

Robert J. Amato, Cherie Perez, Lance Pagliaro

Journal:

Investigational New Drugs

Year:

2002

Language:

english

File:

PDF, 60 KB

english, 2002

7

Does Leucovorin Alter the Intratumoral Pharmacokinetics of 5-Fluorouracil (5-FU)? A Southwest Oncology Group Study

Cary A. Presant, Joth Jacobson, Walter Wolf, Victor Waluch, Ilene C. Weitz, John S. Macdonald

Journal:

Investigational New Drugs

Year:

2002

Language:

english

File:

PDF, 102 KB

english, 2002

8

Licensure of Gemtuzumab Ozogamicin for the Treatment of Selected Patients 60 Years of Age or Older with Acute Myeloid Leukemia in First Relapse

Mark S. Berger, Lance H. Leopold, James A. Dowell, Joan M. Korth-Bradley, Matthew L. Sherman

Journal:

Investigational New Drugs

Year:

2002

Language:

english

File:

PDF, 141 KB

english, 2002

9

Biochemical Modulation of 5-Fluorouacil Through Dihydropyrimidine Dehydrogenase Inhibition: a Southwest Oncology Group Phase II Trial of Eniluracil and 5-Fluorouracil in Advanced Resistant Colorectal Cancer

Cynthia G. Leichman, Kari Chansky, John S. Macdonald, Michael A. Doukas, G. Thomas Budd, Jeffrey K. Giguere, James L. Abbruzzese

Journal:

Investigational New Drugs

Year:

2002

Language:

english

File:

PDF, 71 KB

english, 2002

10

Announcement

Journal:

Investigational New Drugs

Year:

2002

File:

PDF, 19 KB

2002

11

A Phase II Study of Thalidomide in Advanced Metastatic Renal Cell Carcinoma

David R. Minor, Dana Monroe, Lisa A. Damico, Gloria Meng, Uma Suryadevara, Laurence Elias

Journal:

Investigational New Drugs

Year:

2002

Language:

english

File:

PDF, 60 KB

english, 2002

12

Phase I Study of Eniluracil, Oral 5-Fluororacil and Gemcitabine in Patients with Advanced Malignancy

Sherry Morgan-Meadows, James P. Thomas, Daniel Mulkerin, Jordan D. Berlin, Howard Bailey, Kim Binger, Jennifer Volkman, Dona Alberti, Chris Feierabend, Rebecca Marrocha, Rhoda Z. Arzoomanian, George W

Journal:

Investigational New Drugs

Year:

2002

Language:

english

File:

PDF, 63 KB

english, 2002

13

Volume Contents

Journal:

Investigational New Drugs

Year:

2002

Language:

english

File:

PDF, 43 KB

english, 2002

14

Piritrexim in Advanced, Refractory Carcinoma of the Urothelium (E3896): A Phase II Trial of the Eastern Cooperative Oncology Group

Bruce J. Roth, Judith Manola, Robert Dreicer, David Graham, George Wilding

Journal:

Investigational New Drugs

Year:

2002

Language:

english

File:

PDF, 64 KB

english, 2002

15

A Randomized Phase II Study of Two Schedules of Bryostatin-1 (NSC339555) in Patients with Advanced Malignant Melanoma – A National Cancer Institute of Canada Clinical Trials Group Study

R.G. Tozer, S. Burdette-Radoux, K. Berlanger, M.L. Davis, R.C. Lohmann, J.R. Rusthoven, N. Wainman, B. Zee, L. Seymour

Journal:

Investigational New Drugs

Year:

2002

Language:

english

File:

PDF, 69 KB

english, 2002